Estimated antiretroviral therapy coverage among children in South-East Asia (WHO region)
South-East Asia (WHO region): Estimated antiretroviral therapy coverage among children was 11 in 2025. ◆ Volatile
Latest (2025)
11
Change on year
unchanged
Rank
12th
of 13 groups
All-time high
12
in 2018
All-time low
0
in 2000
Years of data
26
2000–2025
Estimated antiretroviral therapy coverage among children in South-East Asia (WHO region), 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for estimated antiretroviral therapy coverage among children in South-East Asia (WHO region) is 11, measured in 2025.
That represents a change of up 10.0% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among children in South-East Asia (WHO region) peaked at 12 in 2018 and was at its lowest, 0, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among children in South-East Asia (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0 | — |
| 2001 | 1 | — |
| 2002 | 1 | +0.0% |
| 2003 | 2 | +100.0% |
| 2004 | 2 | +0.0% |
| 2005 | 3 | +50.0% |
| 2006 | 3 | +0.0% |
| 2007 | 4 | +33.3% |
| 2008 | 4 | +0.0% |
| 2009 | 5 | +25.0% |
| 2010 | 6 | +20.0% |
| 2011 | 6 | +0.0% |
| 2012 | 7 | +16.7% |
| 2013 | 8 | +14.3% |
| 2014 | 9 | +12.5% |
| 2015 | 10 | +11.1% |
| 2016 | 11 | +10.0% |
| 2017 | 11 | +0.0% |
| 2018 | 12 | +9.1% |
| 2019 | 12 | +0.0% |
| 2020 | 12 | +0.0% |
| 2021 | 11 | -8.3% |
| 2022 | 11 | +0.0% |
| 2023 | 11 | +0.0% |
| 2024 | 11 | +0.0% |
| 2025 | 11 | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.5 | 0 | 5 | 10 |
| 2010s | 9.2 | 6 | 12 | 10 |
| 2020s | 11.17 | 11 | 12 | 6 |
Countries ranked near South-East Asia (WHO region)
More health data for South-East Asia (WHO region)
- Pertussis - number of reported cases, gaps filled 2,449 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 84 (2025)
- Total tetanus - number of reported cases, gaps filled 164 (2025)
- Measles - number of reported cases, gaps filled 19,075 (2025)
- Diphtheria - number of reported cases, gaps filled 3,416 (2025)
- Number of under-five deaths, annual growth rate -4.64 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -4.57 % change on previous year (2024)
- Number of infant deaths, annual growth rate -4.21 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -30.44 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -67.98 % change on previous year (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among children in South-East Asia (WHO region)?
- Estimated antiretroviral therapy coverage among children in South-East Asia (WHO region) was 11 in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among children recorded in South-East Asia (WHO region)?
- The highest recorded value was 12 in 2018.
- What is the lowest estimated antiretroviral therapy coverage among children recorded in South-East Asia (WHO region)?
- The lowest recorded value was 0 in 2000.
- How does South-East Asia (WHO region) rank for estimated antiretroviral therapy coverage among children?
- South-East Asia (WHO region) ranks 12th out of 13 groups with data for 2025.
- Is estimated antiretroviral therapy coverage among children rising or falling in South-East Asia (WHO region)?
- Over the last ten years it is up 10.0%. The long-run trend across the full record is volatile.
- Where does this South-East Asia (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among children. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).